DeLiver Pharma ApS — Credit Rating and Financial Key Figures

CVR number: 39432714
Sanatorievej 8, 5600 Faaborg
tel: 21733311

Income statement (kDKK)

2020
2021
2022
2023
2024
Fiscal period length1212121212
Net sales
Gross profit-19.60-21.88-17.95118.66-10.30
Total depreciation-94.26- 125.03-11.38-11.38-11.38
EBIT- 113.85- 146.91-29.33107.28-21.68
Pre-tax profit- 113.85- 146.91-29.33107.28-21.68
Net earnings- 113.85- 146.91-29.33107.28-21.68

Assets (kDKK)

2020
2021
2022
2023
2024
Intangible rights212.1099.0487.6676.2964.91
Intangible assets total212.1099.0487.6676.2964.91
Tangible assets total
Participating interests12.50
Investments total12.50
Non-current loans receivable12.5012.5012.50
Long term receivables total12.5012.5012.50
Inventories total
Current other receivables14.151.4112.260.26
Short term receivables total14.151.4112.260.26
Cash and bank deposits28.2936.568.33182.57128.42
Cash and cash equivalents28.2936.568.33182.57128.42
Balance sheet total (assets)254.54149.52120.75271.36206.09

Equity and liabilities (kDKK)

2020
2021
2022
2023
2024
Share capital220.00260.00260.00260.00260.00
Retained earnings139.5825.73- 121.18- 150.51-43.23
Profit of the financial year- 113.85- 146.91-29.33107.28-21.68
Shareholders equity total245.73138.82109.49216.77195.09
Non-current liabilities total
Current trade creditors10.7011.2620.5411.00
Other non-interest bearing current liabilities8.8134.05
Current liabilities total8.8110.7011.2654.5911.00
Balance sheet total (liabilities)254.54149.52120.75271.36206.09
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.